logoOmicsDI
  • Browse
  • Submit Data
  • Databases
  • API

4 Results

Show all   Save search   Copy query

Show results for

  • UnknownUnknown (4)

Publication Date

Release Date

  • Previous page
  • 1 / 1
  • You're on page 1
  • Next page
Sort   by:  
Relevance
 Page size 
10
UnknownRiluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study.
Not available
S-EPMC2638696 | biostudies-literature
UnknownA new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability.
Not available
S-EPMC3152869 | biostudies-literature
UnknownDisease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS--Parkinson Plus Scale.
Not available
S-EPMC3150329 | biostudies-literature
UnknownThe economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United Kingdom.
Not available
S-EPMC3169589 | biostudies-literature
  • Previous page
  • 1 / 1
  • You're on page 1
  • Next page
Sort   by:  
Relevance
 Page size 
10
OmicsDI is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

EMBL-EBI logoEMBL-EBI logo

OmicsDI Databases

  • PRIDE
  • PeptideAtlas
  • MassIVE
  • JPOST Repository
  • Physiome Model Repository
  • EGA
  • EVA
  • ENA
  • LINCS
  • PAXDB
  • Cell Collective
  • MetaboLights
  • Metabolomics Workbench
  • MetabolomeExpress
  • GNPS
  • BioModels
  • FAIRDOMHub
  • ArrayExpress
  • dbGaP
  • ExpressionAtlas
  • GEO
  • NODE

Information

  • Databases
  • Help
  • API
  • Contact us
  • Code on GitHub
  • Terms of use
  • Submit Data